Isturisa (osilodrostat) can safely reduce, or even normalize, cortisol levels in people with various forms of endogenous Cushing’s syndrome…
Michela Luciano, PhD
Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in acute myeloid leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as a scientific writer in 2022. Outside of work, she enjoys street photography, mountain hikes, running, and spending as much time outdoors as possible.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Michela Luciano, PhD
Despite taking Isturisa (osilodrostat), a medication not recommended during pregnancy, a 38-year-old woman in Japan with recurrent Cushing’s…
A 43-year-old woman with Cushing’s disease developed an unusual sequence of psychiatric complications after rapid increases in her oral cortisol-lowering…
A malignant tumor of the thymus, a small organ in the upper chest that plays a critical role in the…
Researchers have identified ceritinib, a cancer medication, as a promising treatment candidate for Cushing’s disease after successfully using miniature,…
About half of people with Cushing’s disease have abnormalities in their adrenal glands, the small organs above the kidneys…
A 52‑year‑old woman who came to the hospital complaining of chest pain and difficulty breathing was found to have both…
People with endogenous Cushing’s syndrome face a higher risk of cancer compared with the general population, and are twice as…
Early screening and treatment for possible underlying causes of obesity, such as Cushing’s disease, before a weight-loss procedure called…
Sequential treatment with ketoconazole to lower cortisol levels and octreotide to help keep cortisol under control may be effective…